Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Celcuity price target raised to $95 from $70 at Needham
2d ago
CELC
CHRO
Premium
The Fly
Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’
2d ago
CHRO
OLMA
Premium
The Fly
Genentech announces FDA approval for Gazyva for active lupus nephritis
2d ago
CHRO
Premium
The Fly
Genentech announces results from IMvigor011 study
2d ago
CHRO
Premium
The Fly
Roche announces results from phase III evERA Breast Cancer study
3d ago
CHRO
Premium
The Fly
Genentech’s Phase III evERA data showed giredestrant improved PFS survival
3d ago
CHRO
Premium
The Fly
Genentech presents new Phase 3 data for vamikibart
4d ago
CHRO
Premium
The Fly
Roche reports Phase 3 data for satralizumab in SatraGO-1, SatraGO-2
5d ago
CHRO
Premium
The Fly
Underwhelming Roche data helps Veridian’s position in TED, says Jefferies
5d ago
CHRO
VRDN
Premium
The Fly
CHMP recommends EU approval of Roche’s Gazyva/Gazyvaro for lupus nephritis
5d ago
CHRO
Premium
The Fly
Roche announces Direct-to-Patient program for Xofluza
6d ago
CHRO
Premium
The Fly
Roche says FDA clears Elecsys pTau181 test
9d ago
CHRO
Premium
The Fly
Roche to present 30 abstracts at ESMO, evERA study met co-primary endpoints
9d ago
CHRO
Premium
The Fly
Natera to present 14 studies to be presented at ESMO Congress
9d ago
CHRO
NTRA
Premium
The Fly
Trump Weekly: Generics to be excluded from pharma tariff plan
11d ago
C
ES
Premium
The Fly
Trump Trade: GoodRx, others in talks with White House to join TrumpRx
12d ago
AZN
BMY
Premium
The Fly
GoodRx, others in talks with White House to join TrumpRx, Reuters reports
13d ago
AZN
BMY
Premium
The Fly
Trump Trade: Generics to be excluded from pharma tariff plan
13d ago
AZN
BMY
Premium
The Fly
Generics to be excluded from Trump’s pharma tariff plan, WSJ reports
13d ago
AZN
BMY
Premium
The Fly
Exicure appoints Josephine Cardarelli as president, CSO
16d ago
BMY
CHRO
Premium
The Fly
Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
18d ago
CI
GH
Premium
The Fly
Trump Weekly: White House announces drug pricing deal with Pfizer
18d ago
BG
CF
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
